(264 days)
Not Found
No
The description details a chemical disinfectant solution and its use, with no mention of AI or ML technologies.
No.
Minncare HD is a disinfectant for water purification systems used in hemodialysis, not a device directly used in therapy or treatment of a patient.
No
The device is a disinfectant used for water purification systems in hemodialysis, not a tool for diagnosing medical conditions. Its purpose is to clean and sanitize, not to detect or identify diseases or conditions.
No
The device is a liquid disinfectant solution, which is a chemical substance, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "disinfection of water purification systems for hemodialysis." This is a process related to maintaining equipment, not directly testing a biological sample from a patient to diagnose or monitor a medical condition.
- Device Description: The description details a disinfectant solution used to clean equipment. It mentions test strips, but these are for confirming the concentration and residual levels of the disinfectant itself, not for analyzing a patient sample.
- Lack of IVD Characteristics: The description does not mention analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing information for diagnosis, monitoring, or treatment decisions based on patient samples.
Therefore, Minncare HD is a disinfectant for medical equipment, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Minncare HD is intended for the disinfection of water purification systems for hemodialysis. It should be diluted to a 1% concentration (1 part Minncare HD to 99 parts water) and used for a minimum contact time of 36 minutes at 20°C.
Product codes (comma separated list FDA assigned to the subject device)
NIH
Device Description
Minncare HD is a clear liquid disinfectant solution that consists of a stabilized mixture of hydrogen peroxide, peracetic acid and acetic acid. Minncare HD is intended to be used for hemodialysis water purification system disinfection when diluted to a 1% concentration (1 part Minncare HD to 99 parts water) and applied for a minimum contact time of 36 minutes at 20℃. The active microbicidal ingredient is peracetic acid (PAA), and the recommended use concentration of 1%. The concentration of the use solution should be confirmed with 1% Minncare HD indicator test strips to have reached the furthest point of the distribution loop during the system disinfection contact time. Upon completion of disinfection the system must be rinsed to remove residual levels of the disinfectant. Residual levels should be checked using Minncare HD residual test strips to ensure residual levels of 1 ppm PAA or less. Minncare HD is supplied in cases containing high density polyethylene plastic bottles. Individual bottles are labeled with all information necessary to use the device safely.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing has been conducted to show that Minncare HD is safe and effective for its intended use. The following types of data/information are provided in this submission in support of substantial equivalence to predicate device and to demonstrate that Minncare HD performs safely as intended.
- Detailed description of physical and chemical properties .
- Proposed labeling .
- Sporicidal, tuberculocidal, fungicidal, virucidal and bactericidal efficacy ●
- Simulated-use disinfection efficacy .
- . Material compatibility
- Test strip performance .
- Stability .
- Risk Analysis ●
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5665 Water purification system for hemodialysis.
(a)
Identification. A water purification system for hemodialysis is a device that is intended for use with a hemodialysis system and that is intended to remove organic and inorganic substances and microbial contaminants from water used to dilute dialysate concentrate to form dialysate. This generic type of device may include a water softener, sediment filter, carbon filter, and water distillation system.(b)
Classification. Class II (special controls). The device, when it is a water purification subsystem disinfectant, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features the department's name in a circular arrangement around the perimeter. At the center of the seal is a stylized representation of a human figure, composed of three overlapping profiles facing to the right. The seal is rendered in black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 27, 2014
MEDIVATORS, INC. Mrs. Kinnari Shah Senior Regulatory Affairs Specialist 14605 28th Ave. North Minneapolis, MN 55447
Re: K133724
Trade/Device Name: Minncare HD® Disinfectant Regulation Number: 21 CFR 876.5665 Regulation Name: Disinfectant, subsystem, water purification Regulatory Class: II Product Code: NIH Dated: July 30, 2014 Received: July 31, 2014
Dear Mrs. Shah:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
1
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Erin I. Keith -S
Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/0 description: The image shows the logo for Medivators, a Cantel Medical Company. The logo consists of a blue circular graphic on the left, followed by the word "MEDIVATORS" in blue, sans-serif font. Below the company name is the text "A Cantel Medical Company" in a smaller, sans-serif font, also in blue. The logo is clean and professional, conveying a sense of trust and reliability.
Indications for Use
510(k) number (if known): K133724
Device Name: Minncare® HD Disinfectant
Indications for Use:
Minncare HD is intended for the disinfection of water purification systems for hemodialysis. It should be diluted to a 1% concentration (1 part Minncare HD to 99 parts water) and used for a minimum contact time of 36 minutes at 20°C.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use (Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
3
Image /page/3/Picture/0 description: The image shows the logo for Medivators, a Cantel Medical Company. The logo consists of a blue circular graphic on the left, followed by the word "MEDIVATORS" in blue, sans-serif font. Below the company name, in a smaller font size, is the text "A Cantel Medical Company" also in blue. The overall design is clean and corporate, suggesting a professional and medical-related business.
Minncare® HD Disinfectant
510(k) Summary
| Manufacturer: | Medivators Inc., a Cantel Medical Company |
|---|---|
| Address: | 14605 28th Avenue North |
| Minneapolis, MN 55447 USA | |
| (800) 328-3345 | |
| Official Contact: | Kinnari Shah |
| Senior Regulatory Affairs Specialist | |
| Date Prepared: | 13th August 2014 |
| Trade Name: | Minncare® HD Disinfectant |
| Common Name: | Water Purification System Disinfectant |
| Classification Name: | Disinfectant, subsystem, water purification |
| Product Code: | NIH |
| Device Class: | II |
| Classification Reg: | 876.5665 |
| 510k: | K133724 |
Medivators Inc. has supplied the following information to the US Food and Drug Administration to support substantial equivalence of the Minncare HD Disinfectants to other disinfectants currently cleared for sale in the U.S.
1. Intended Use
Minncare HD is intended for the disinfection of water purification systems for hemodialysis. It should be diluted to a 1% concentration (1 part Minncare HD to 99 parts water) and used for a minimum contact time of 36 minutes at 20℃.
2. Device Description
Minncare HD is a clear liquid disinfectant solution that consists of a stabilized mixture of hydrogen peroxide, peracetic acid and acetic acid. Minncare HD is intended to be used for hemodialysis water purification system disinfection when diluted to a 1% concentration (1 part Minncare HD to 99 parts water) and applied for a minimum contact time of 36 minutes at 20℃. The active microbicidal ingredient is peracetic acid (PAA), and the recommended use concentration of 1%. The concentration of the use solution should be confirmed with 1% Minncare HD indicator test strips to have reached the furthest point of the distribution loop during the system disinfection contact time. Upon completion of disinfection the system must be rinsed to remove residual levels of the disinfectant. Residual levels should be
4
Image /page/4/Picture/0 description: The image shows the logo for Medivators, a Cantel Medical Company. The logo consists of a blue circular graphic on the left, followed by the word "MEDIVATORS" in blue, block letters. Below the company name is the text "A Cantel Medical Company" in a smaller, blue font. The logo is simple and professional, conveying a sense of trust and reliability.
checked using Minncare HD residual test strips to ensure residual levels of 1 ppm PAA or less. Minncare HD is supplied in cases containing high density polyethylene plastic bottles. Individual bottles are labeled with all information necessary to use the device safely.
3. Comparison to Other Device in Commercial Distribution Within the United States
MEDIVATORS Inc. believes Minncare HD is substantially equivalent in formulation, performance and indications to its predicate device - Hemoclean Disinfectant which is cleared under 510k - K023064. Hemoclean is a peracetic acid based liguid chemical germicide disinfectant solutions with similar chemistry, intended use and disinfectant performance to Minncare HD. Below is the comparison between the subject and the predicate device -
| Item | Minncare HD
MEDIVATORS Inc. | Hemoclean
Disinfectant
KRD CO., LTD
(K023064) |
|------------------------------------------------------------|------------------------------------------------|-----------------------------------------------------------------------|
| Active Ingredient | Peracetic Acid/ Hydrogen
Peroxide | Peracetic Acid/ Hydrogen
Peroxide |
| Device Use Indication | Water Purification
Systems for Hemodialysis | Hemodialysis machines,
Water Purification
Systems and Dialyzers |
| Form | Liquid solution | Liquid solution |
| Dilution Required | Yes | Yes |
| Minimum Contact Time | 36 minutes | 10 minutes |
| Use Temperature | 20°C | 20°C |
| Minimum Use
Concentration | 1% | 3% |
| Active Ingredient
Nominal Concentration | 5% / 22% | 1.7%/5.3% |
| Single Use | Yes | Yes |
| Sterilization Claim | No | No |
| Use and Compatibility
with Water Purification
System | Yes | Yes |
| Shelf-Life | 12 months | 12 months |
| Test Strip Used to
Monitor MRC | Yes | Yes |
5
4. Summary of Non-Clinical Performance Data
FDA Guidance for content of premarket notification submissions for water purification system disinfectants (product code NIH) has not been established, and thus performance testing requirements were based on related FDA Guidance for Content and Format of Premarket Notification [510(k)] Submission for Liquid Chemical Sterilants/High Level Disinfectants (Jan 2000). However, it is important to note that Minncare HD is not intended to be used on critical or semi-critical devices and high-level disinfection is not claimed.
Performance testing has been conducted to show that Minncare HD is safe and effective for its intended use. The following types of data/information are provided in this submission in support of substantial equivalence to predicate device and to demonstrate that Minncare HD performs safely as intended.
- Detailed description of physical and chemical properties .
- Proposed labeling .
- Sporicidal, tuberculocidal, fungicidal, virucidal and bactericidal efficacy ●
- Simulated-use disinfection efficacy .
- . Material compatibility
- Test strip performance .
- Stability .
- Risk Analysis ●
5. Conclusion
The performance testing data indicates that the subject device, Minncare HD, is substantially equivalent to the predicate device Hemoclean Disinfectant (K023064).